Qualitative feasibility study of the mobile app Destroke for clinical stroke monitoring based on the NIH stroke scale.

Autor:	Noch EK; Department of Neurology, Weill Cornell Medicine, New York, NY, USA.; Destroke, Inc., USA., Pham D; Destroke, Inc., USA., Kitago T; Westchester Medical Center, Valhalla, NY, USA., Wuennemann M; Burke Neurological Institute, White Plains, NY, USA., Wortman-Jutt S; Burke Neurological Institute, White Plains, NY, USA., Falo MC; Westchester Medical Center, Valhalla, NY, USA.
Jazyk:	angličtina
Zdroj:	Heliyon [Heliyon] 2023 Jul 20; Vol. 9 (8), pp. e18393. Date of Electronic Publication: 2023 Jul 20 (Print Publication: 2023).
DOI:	10.1016/j.heliyon.2023.e18393
Abstrakt:	Background: Stroke is a leading cause of severe disability in the United States, but there is no effective method for patients to accurately detect the signs of stroke at home. We developed a mobile app, Destroke, that allows remote performance of a modified NIH stroke scale (NIHSS) by patients. Aims: To assess the feasibility of a mobile app for stroke monitoring and education by patients with a history of stroke. Materials and Methods: We enrolled 25 patients with a history of stroke in a prospective open-label study to evaluate the feasibility of the Destroke app in patients with stroke. Nineteen patients completed all study assessments, with a median time from stroke onset to enrollment of 5.6 years (range 0.1-12 years). We designed a modified NIHSS that assessed 12 out of 16 tasks on the NIHSS. Patients completed this test eight times over a 28-day period. We conducted pre-study surveys that assessed demographic information, stroke and cardiovascular history, baseline NIHSS, and experience using mobile technologies, and mid- and post-study surveys that assessed patient satisfaction on app usage and confidence in stroke detection. Results: Ten men and nine women participated in this study (median age of 64 (33-76)), representing ten US states and Washington D.C. Median baseline NIHSS was 0 (0-4). 15 patients reported using health apps. On a 5-point Likert scale, patients rated the app as 4.2 on being able to understand and use the app and 4.3 on using the app when instructed by their doctor. For eight patients with poor confidence in detecting the signs of a stroke before the study, six showed higher confidence after the study. Conclusions: The use of an at-home stroke monitoring app is feasible by patients with a history of stroke and improves confidence in detecting the signs of stroke. Competing Interests: Dan Pham reports financial support was provided by Destroke. Evan Noch has patent #16/861383 issued to Destroke, Inc. E.K.N. is a founder and CEO of Destroke, which is developing mobile technologies for clinical stroke detection. Dan Pham is employed by Destroke. (© 2023 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu